1. Home
  2. BDSX vs SFST Comparison

BDSX vs SFST Comparison

Compare BDSX & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • SFST
  • Stock Information
  • Founded
  • BDSX 2005
  • SFST 1999
  • Country
  • BDSX United States
  • SFST United States
  • Employees
  • BDSX N/A
  • SFST N/A
  • Industry
  • BDSX Precision Instruments
  • SFST Major Banks
  • Sector
  • BDSX Health Care
  • SFST Finance
  • Exchange
  • BDSX Nasdaq
  • SFST Nasdaq
  • Market Cap
  • BDSX 194.9M
  • SFST 344.3M
  • IPO Year
  • BDSX 2020
  • SFST 1999
  • Fundamental
  • Price
  • BDSX $1.51
  • SFST $40.65
  • Analyst Decision
  • BDSX Strong Buy
  • SFST Buy
  • Analyst Count
  • BDSX 4
  • SFST 1
  • Target Price
  • BDSX $3.08
  • SFST $44.00
  • AVG Volume (30 Days)
  • BDSX 308.8K
  • SFST 18.6K
  • Earning Date
  • BDSX 11-01-2024
  • SFST 01-16-2025
  • Dividend Yield
  • BDSX N/A
  • SFST N/A
  • EPS Growth
  • BDSX N/A
  • SFST N/A
  • EPS
  • BDSX N/A
  • SFST 1.73
  • Revenue
  • BDSX $65,562,000.00
  • SFST $90,166,000.00
  • Revenue This Year
  • BDSX $46.97
  • SFST N/A
  • Revenue Next Year
  • BDSX $30.43
  • SFST $13.55
  • P/E Ratio
  • BDSX N/A
  • SFST $23.01
  • Revenue Growth
  • BDSX 48.92
  • SFST 3.18
  • 52 Week Low
  • BDSX $1.11
  • SFST $24.98
  • 52 Week High
  • BDSX $2.21
  • SFST $45.91
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • SFST 43.15
  • Support Level
  • BDSX $1.24
  • SFST $39.47
  • Resistance Level
  • BDSX $1.43
  • SFST $42.99
  • Average True Range (ATR)
  • BDSX 0.10
  • SFST 1.30
  • MACD
  • BDSX 0.01
  • SFST -0.58
  • Stochastic Oscillator
  • BDSX 64.44
  • SFST 26.34

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

Share on Social Networks: